[Assessment of BCG vaccine practices]

Arch Pediatr. 2016 Jan;23(1):34-8. doi: 10.1016/j.arcped.2015.10.001. Epub 2015 Nov 6.
[Article in French]

Abstract

Tuberculosis is a major public health problem. In France, the vaccine against tuberculosis (Bacillus Calmette-Guerin, BCG) is in decline. This decline is firstly due to changes in BGG administration that were implemented in 2006 and secondly because of new recommandations in 2007 that ended compulsory vaccination. To determine their position on this vaccine, in 2013-2014 we asked general practitioners, pediatricians, and Maternal and Infantile Protection Center physicians in the Gard and Herault departments (in Southern France) why this vaccine was not administered and their suggestions for improvement. Most of these doctors (73.9%) stated that they did not oppose this vaccination for children. They expressed concern about potential side effects, technical problems (intradermic injection, multi-dose bottles) and parents' refusal. One quarter of these physicians would have preferred that this vaccine remains compulsory and one third that this vaccine be administered in the maternity hospital. They also requested simplified criteria for patient eligibility, technical improvements (training for intradermal injection, single-dose vaccine) and more information for the public concerning this vaccination.

MeSH terms

  • Attitude of Health Personnel*
  • BCG Vaccine*
  • Child
  • France
  • General Practitioners
  • Humans
  • Mass Vaccination / legislation & jurisprudence
  • Middle Aged
  • Parents
  • Pediatrics
  • Practice Patterns, Physicians'*
  • Surveys and Questionnaires

Substances

  • BCG Vaccine